http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1435486-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56ee5285e8e8edccb061046ff20da7a6 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-088 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-096 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-092 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-088 |
| filingDate | 1975-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1976-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1435486-A |
| titleOfInvention | 1-3-naphth-1-yloxy-propyl-piperazine derivatives |
| abstract | 1435486 Naphthoxypropylpiperazine derivatives BOEHRINGER MANNHEIM GmbH 17 Feb 1975 [23 Feb 1974] 6549/75 Heading C2C The invention comprises the compounds of formula wherein X is H or MeO, and their pharmacologically compatible salts. In examples, these compounds are prepared by reacting either 1- naphthol with 1 - (3 - chloropropyl) - 4 - XC 6 H 4 - piperazine, or 1 - (3 - bromopropoxy) - naphthalene with 1-XC 6 (H 4 -piperazine. Therapeutic compositions having bloodpressure lowering, and thus antihypertensive activity, comprise compounds of the above formula, and are preferably administered orally. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0021368-A1 |
| priorityDate | 1974-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.